Aurora Innovation (AUR) Financials

Aurora Innovation continues to operate as a pre-profit company, with modest revenue growth but substantial and rising operating losses. Revenue increased from essentially zero in 2024 and the first quarter of 2025 to $1 million in Q2 2025, $1 million in Q1 2026 and $2 million in Q2 2026. However, Q2 2026 cost of revenue was $7 million, producing a $5 million gross loss. Net loss widened to $270 million from $223 million in Q1 2026 and $201 million in Q2 2025.

Operating expenses remain the primary driver of losses. Total operating expenses rose from $193 million in Q1 2024 to $261 million in Q2 2026, including $211 million of research and development and $50 million of selling, general and administrative expense. Operating cash flow was negative in every period provided, reaching an outflow of $225 million in Q2 2026 compared with $159 million in Q1 2026. This suggests Aurora has not yet demonstrated meaningful operating leverage despite beginning to report commercial revenue.

The balance sheet remains relatively strong, but the company is consuming cash and relying on financing. Cash and short-term investments totaled approximately $1.22 billion at June 30, 2026, while total liabilities were only $214 million and shareholders’ equity was $1.95 billion. Aurora raised $226 million through common equity issuance in Q2 2026, following $21 million in Q1 2026 and larger equity raises in several earlier periods. While these financings support liquidity, they increase dilution risk: weighted-average basic shares rose to 1.976 billion in Q2 2026 from 1.179 billion in Q2 2023.

• Liquidity remains substantial: Aurora held $1.217 billion in cash and short-term investments at the end of Q2 2026, providing a meaningful financial cushion for continued development.
• Low leverage: Total liabilities of $214 million were small relative to total assets of $2.167 billion and shareholders’ equity of $1.953 billion.
• Revenue is beginning to emerge: Quarterly revenue reached $2 million in Q2 2026, double the level reported in the prior two quarters, although the base remains very small.
• Investment portfolio activity has supported liquidity management: Sales and maturities of investments have frequently offset investment purchases, helping the company fund operations without relying entirely on new debt.
• Research and development spending remains elevated: R&D expense reached $211 million in Q2 2026, reflecting continued investment in autonomous-driving technology but also creating a significant burden that must eventually produce commercial returns.
• Balance-sheet assets are shifting: Short-term investments increased to $1.081 billion in Q2 2026, while long-term investments fell to zero, indicating a greater concentration in current and presumably more liquid holdings.
• Operating cash burn is worsening: Cash used in operating activities increased to $225 million in Q2 2026 from $159 million in Q1 2026 and $144 million in Q2 2025.
• Losses continue to expand: The Q2 2026 net loss of $270 million was the largest quarterly loss in the data set, compared with $193 million in Q4 2024 and $190 million in Q3 2023.
• Revenue is not yet covering direct costs: Aurora reported $2 million of revenue against $7 million of cost of revenue in Q2 2026, resulting in a negative gross margin before operating expenses.
• Shareholder dilution is a major risk: Common-equity issuance and rising share counts have been recurring sources of funding, with weighted-average basic shares increasing approximately 68% from Q2 2023 to Q2 2026.